Polypoidal choroidal vasculopathy and treatments

Current Opinion in Ophthalmology

Volumn 19, Issue 3, 2008, Pages 208-212

  Gomi, Fumi ^a,b   Tano, Yasuo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Age related macular degeneration; Bevacizumab; Indocyanine green angiography; Photodynamic therapy; Polypoidal choroidal vasculopathy

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; VERTEPORFIN;

ADVERSE OUTCOME; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG EFFICACY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTRAOCULAR HEMORRHAGE; LOW LEVEL LASER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; POLYPOIDAL CHOROIDAL VASCULOPATHY; PREVALENCE; PRIORITY JOURNAL; RETINA DETACHMENT; REVIEW; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION;

ANGIOGENESIS INHIBITORS; CHOROID; CHOROID DISEASES; DIAGNOSIS, DIFFERENTIAL; FLUORESCEIN ANGIOGRAPHY; HUMANS; LASER COAGULATION; PERIPHERAL VASCULAR DISEASES; PHOTOCHEMOTHERAPY; PREVALENCE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; UNITED STATES;

EID: 42149115080     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3282fb7c33     Document Type: Review

References (53)

1. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990; 10:1-8.
2. Yannuzzi LA, Ciardella A, Spaide RF, et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997; 115:478-485.
3. Yannuzzi LA, Wong DWK, Storzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999; 117:1503-1510.
4. Moorthy RS, Lyon AT, Rabb MF, et al. Idiopathic choroidal vasculopathy of the macula. Ophthalmology 1998; 105:1380-1385.
5. Kleiner RC, Bruker AJ, Johnson RL. The posterior uveal bleeding syndrome. Retina 1990; 10:9-17.
6. Ahuja RM, Stanga PE, Vingerling JR, et al. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelial detachments. Br J Ophthalmol 2000; 84:479-484.
7. Lafaut BA, Leys AM, Snyers B, et al. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000; 20:650-654.
8. Kwok AK, Lai TY, Chan CW, et al. Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol 2002; 86:892-897.
9. Uyama M, Matsubara T, Fukushima I, et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 1999; 117:1035-1042.
10. Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: Incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003; 121:1392-1396.
11. Wen F, Chen C, Wu D, Li H. Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 2004; 242:625-629.
12. Ladas ID, Rouvas AA, Moschos MM, et al. Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye 2004; 18:455-459.
13. Kondo N, Honda S, Ishibashi K, et al. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 2007; 144:608-612. This is an important report showing that PCV and AMD share the same genetic background.
14. Obata R, Yanagi Y, Kami J, et al. Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration. Jpn J Ophthalmol 2006; 50:354-360.
15. Gomi F, Ohji M, Sayanagi K, et al. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology (in press). Our study revealed the high prevalence of PCV in Japanese AMD patients and the marked difference in the responses to PDT between PCV and AMD. PCV had significantly better 1-year visual and angiographic outcomes than AMD.
16. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials: TAP report 1. Arch Ophthalmol 1999; 117:1329-1345.
17. Maruko I, Iida T, Saito M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007; 144:15-22.
18. Tsujikawa A, Sasahara M, Otani A, et al. Pigment epithelial detachment in polypoidal choroidal vasculopathy. Am J Ophthalmol 2007; 143:102-111.
19. Yannuzzi LA, Freund KB, Goldbaum M, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000; 107:767-777.
20. Ahuja RM, Downes SM, Stanga PE, et al. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 2001; 108:1009-1010.
21. Gomi F, Sawa M, Mitarai K, et al. Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007; 245:1421-1427.
22. Tamura H, Tsujikawa A, Otani A, et al. Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularisation on fluorescein angiography. Br J Ophthalmol 2007; 91:1152-1159.
23. Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995; 15:100-110.
24. Okubo A, Ito M, Sameshima M, et al. Pulsatile blood flow in the polypoidal choroidal vasculopathy. Ophthalmology 2005; 112:1436-1441.
25. Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005; 89:602-607.
26. Iijima H, Imai M, Gohdo T, Tsukahara S. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 1999; 127:301-305.
27. Iijima H, Iida T, Imai M, et al. Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2000; 129:21-26.
28. Otsuji T, Takahashi K, Fukushima I, Uyama M. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers 2000; 31:210-214.
29. Sato T, Kishi S, Watanabe G, et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007; 27:589-594.
30. Uyama M, Wada M, Nagai Y, et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 2002; 133:639-648.
31. Gomez-Ulla F, Gonzales F, Torreiro MG. Diode laser photocoagulation in idiopathic polypoidal choroidal vasculopathy. Retina 1998; 18:481-483.
32. Yuzawa M, Mori R, Haruyama M. A study of laser photocoagulation for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2003; 47:379-384.
33. Nishijima K, Takahashi M, Akita J, et al. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2004; 137:770-773.
34. Costa RA, Navajas EV, Farah ME, et al. Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. Prog Retin Eye Res 2005; 24:560-586.
35. Quaranta M, Mauget-Faysse M, Coscas G. Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Am J Ophthalmol 2002; 134:277-280.
36. Spaide RF, Donsoff I, Lam DL, et al. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina 2002; 22:529-535.
37. Chan WM, Lam DS, Lai TY, et al. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy. Ophthalmology 2004; 111:1576-1584.
38. Lee SC, Seong YS, Kim SS, et al. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula. Ophthalmologica 2004; 218:193-201.
39. Silva RM, Figueira J, Cachulo ML, et al. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2005; 243:973-979.
40. Mauget-Faysse M, Quaranta-El Maftouhi M, De La Marnierre E, Leys A. Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy. Eur J Ophthalmol 2006; 16:695-704.
41. Otani A, Sasahara M, Yodoi Y, et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007; 144:7-14.
42. Akaza E, Yuzawa M, Matsumoto Y, et al. Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2007; 51:270-277. This study provided evidence that persistent abnormal choroidal vascular networks after PDT are associated with recurrent polypoidal lesions.
43. Eandi CM, Ober MD, Freund KB, et al. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 2007; 27:825-831.
44. Imai H, Honda S, Nakanishi Y, et al. Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy. Br J Ophthalmol 2006; 90:1524-1530.
45. Yodoi Y, Tsujikawa A, Kameda T, et al. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007; 143:984-994.
46. Sayanagi K, Gomi F, Sawa M, et al. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2007; 245:1569-1571.
47. Hirami Y, Tsujikawa A, Otani A, et al. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 2007; 27:335-341. This study revealed the details of the hemorrhage after PDT for PCV.
48. Ojima Y, Tsujikawa A, Otani A, et al. Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy. Am J Ophthalmol 2006; 141:958-960.
49. Prakash M, Han DP. Recurrent bullous retinal detachments from photodynamic therapy for idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2006; 142:1079-1081.
50. Matsuoka M, Ogata N, Otsuji T, et al. Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy. Br J Ophthalmol 2004; 88:809-815.
51. Tong JP, Chan WM, Liu DT, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006; 141:456-462.
52. Gomi F, Sawa M, Sakaguchi H, et al. Efficacy of Intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol (in press). This is the first report to evaluate the efficacy of intravitreal bevacizumab for PCV.
53. Ghajarnia M, Kurup S, Eller A. The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy. Semin Ophthalmol 2007; 22:127-131.